Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Mexico - Delayed Quote • MXN Incyte Corporation (INCY.MX) Follow Add holdings 1,430.49 0.00 (0.00%) At close: March 6 at 12:37:40 PM CST Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for INCY.MX 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: INCY.MX View More All News Press Releases SEC Filings High Growth Tech Stocks in US with Strong Potential for Investors Incyte to Present at Upcoming Investor Conference Incyte First Quarter 2025 Earnings: Beats Expectations Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs Incyte to Highlight Early-Stage Oncology Data at American Association for Cancer Research Annual Meeting 2025 Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Incyte to Report First Quarter Financial Results Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Exploring 3 High Growth Tech Stocks In The US Market Knight Therapeutics Announces Launch of Minjuvi® (tafasitamab) in Mexico Incyte price target lowered to $72 from $74 at Truist